GB9201180D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9201180D0
GB9201180D0 GB929201180A GB9201180A GB9201180D0 GB 9201180 D0 GB9201180 D0 GB 9201180D0 GB 929201180 A GB929201180 A GB 929201180A GB 9201180 A GB9201180 A GB 9201180A GB 9201180 D0 GB9201180 D0 GB 9201180D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929201180A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
GlaxoSmithKline SpA
Original Assignee
Glaxo Group Ltd
Glaxo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Glaxo SpA filed Critical Glaxo Group Ltd
Priority to GB929201180A priority Critical patent/GB9201180D0/en
Priority to GEAP19922651A priority patent/GEP20001968B/en
Publication of GB9201180D0 publication Critical patent/GB9201180D0/en
Priority to ES93200097T priority patent/ES2121925T3/es
Priority to SG1996007401A priority patent/SG52655A1/en
Priority to AT93200097T priority patent/ATE169007T1/de
Priority to US08/256,359 priority patent/US5580895A/en
Priority to EP93200097A priority patent/EP0558104B1/en
Priority to DE69319945T priority patent/DE69319945T2/de
Priority to DK93200097T priority patent/DK0558104T3/da
Priority to SK864-94A priority patent/SK280173B6/sk
Priority to RU94037768A priority patent/RU2124009C1/ru
Priority to UA94005364A priority patent/UA29416C2/uk
Priority to KR1019940702491A priority patent/KR100263625B1/ko
Priority to HU9402150A priority patent/HU221297B1/hu
Priority to PL93304684A priority patent/PL175340B1/pl
Priority to AU34501/93A priority patent/AU3450193A/en
Priority to PCT/EP1993/000098 priority patent/WO1993014074A1/en
Priority to CZ941736A priority patent/CZ283950B6/cs
Priority to RO94-01216A priority patent/RO114128B1/ro
Priority to IL104447A priority patent/IL104447A/en
Priority to NZ245715A priority patent/NZ245715A/en
Priority to CA002087672A priority patent/CA2087672C/en
Priority to ZA93375A priority patent/ZA93375B/xx
Priority to APAP/P/1993/000478A priority patent/AP369A/en
Priority to JP02483193A priority patent/JP3253723B2/ja
Priority to PH45583A priority patent/PH30894A/en
Priority to AU31935/93A priority patent/AU661749B2/en
Priority to MYPI93000093A priority patent/MY131307A/en
Priority to MX9300261A priority patent/MX9300261A/es
Priority to IS3970A priority patent/IS3970A/is
Priority to CN93101143A priority patent/CN1049217C/zh
Priority to TW082100666A priority patent/TW226013B/zh
Priority to BG98881A priority patent/BG61876B1/bg
Priority to OA60539A priority patent/OA09964A/en
Priority to FI943421A priority patent/FI111632B/fi
Priority to NO942720A priority patent/NO305952B1/no
Priority to HU95P/P00242P priority patent/HU211295A9/hu
Priority to US08/674,259 priority patent/US5637697A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB929201180A 1992-01-21 1992-01-21 Chemical compounds Pending GB9201180D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GB929201180A GB9201180D0 (en) 1992-01-21 1992-01-21 Chemical compounds
GEAP19922651A GEP20001968B (en) 1992-01-21 1992-01-21 Arilthio Compounds as Antibacterial and Antiviral Agents
ES93200097T ES2121925T3 (es) 1992-01-21 1993-01-15 Derivados de 1,5-benzodiacepina y su uso en medicina.
SG1996007401A SG52655A1 (en) 1992-01-21 1993-01-15 1,5 Benzodiazepine derivatives and their use in medicine
AT93200097T ATE169007T1 (de) 1992-01-21 1993-01-15 1,5-benzodiazepinderivate und deren verwendung in heilmittel
US08/256,359 US5580895A (en) 1992-01-21 1993-01-15 1,5-benzodiazepine derivatives
EP93200097A EP0558104B1 (en) 1992-01-21 1993-01-15 1,5-Benzodiazepine derivatives and their use in medicine
DE69319945T DE69319945T2 (de) 1992-01-21 1993-01-15 1,5-Benzodiazepinderivate und deren Verwendung in Heilmittel
DK93200097T DK0558104T3 (da) 1992-01-21 1993-01-15 1,5-Benzodiazepinderivater og deres anvendelse i lægemidler
SK864-94A SK280173B6 (sk) 1992-01-21 1993-01-19 1,5-benzodiazepínové deriváty, spôsob ich výroby,
RO94-01216A RO114128B1 (ro) 1992-01-21 1993-01-19 Derivati de 1,5-benzodiazepina, procedeu de preparare a acestora, compozitii farmaceutice care ii contin si metoda de tratament
RU94037768A RU2124009C1 (ru) 1992-01-21 1993-01-19 Производные 1,5-бензодиазепина, способ их получения, фармацевтическая композиция
UA94005364A UA29416C2 (uk) 1992-01-21 1993-01-19 Похідні 1,5 - бензодіазепіну, що є антагоністами гастрину та холецистокініну, спосіб їх одержання, фармацевтична композиція
KR1019940702491A KR100263625B1 (ko) 1992-01-21 1993-01-19 1,5-벤조디아제핀유도체및그의의약으로서의용도
HU9402150A HU221297B1 (en) 1992-01-21 1993-01-19 1,5-benzodiazepine derivatives, pharmaceutical compositions containing them and process for their producing
PL93304684A PL175340B1 (pl) 1992-01-21 1993-01-19 Pochodne 1,5-benzodiazepiny, kompozycja farmaceutyczna i sposób wytwarzania pochodnych 1,5-benzodiazepiny
AU34501/93A AU3450193A (en) 1992-01-21 1993-01-19 1,5-benzodiazepine derivatives and their use in medicine
PCT/EP1993/000098 WO1993014074A1 (en) 1992-01-21 1993-01-19 1,5-benzodiazepine derivatives and their use in medicine
CZ941736A CZ283950B6 (cs) 1992-01-21 1993-01-19 1,5-Benzodiazepinové deriváty a jejich použití v medicíně
IL104447A IL104447A (en) 1992-01-21 1993-01-20 1, 5-benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
IS3970A IS3970A (is) 1992-01-21 1993-01-20 Hliðstæð aðferð til framleiðslu á 1,5-benzódíazepín afleiðum
MX9300261A MX9300261A (es) 1992-01-21 1993-01-20 Derivados de 1,5-benzodiacepina, proceso para su preparacion y composicion farmaceutica que los contiene.
CA002087672A CA2087672C (en) 1992-01-21 1993-01-20 1,5-benzodiazepine derivatives
ZA93375A ZA93375B (en) 1992-01-21 1993-01-20 1,5-benzodiazepine derivatives
APAP/P/1993/000478A AP369A (en) 1992-01-21 1993-01-20 1,5-Benzodiazepine derivatives.
JP02483193A JP3253723B2 (ja) 1992-01-21 1993-01-20 １，５‐ベンゾジアゼピン誘導体
PH45583A PH30894A (en) 1992-01-21 1993-01-20 1,5-Benzodiazepine derivative.
AU31935/93A AU661749B2 (en) 1992-01-21 1993-01-20 1,5-benzodiazepine derivatives
MYPI93000093A MY131307A (en) 1992-01-21 1993-01-20 1,5-benzodiazepine derivatives
NZ245715A NZ245715A (en) 1992-01-21 1993-01-20 2,4-dioxo-1,5-benzodiazepin-3-yl urea derivatives and medicaments
CN93101143A CN1049217C (zh) 1992-01-21 1993-01-21 1,5－苯并二氮杂䓬衍生物及其制法以及含它们的药用组合物
TW082100666A TW226013B (OSRAM) 1992-01-21 1993-02-02
BG98881A BG61876B1 (bg) 1992-01-21 1994-06-27 Производни на 1,5-бензодиазепина
OA60539A OA09964A (en) 1992-01-21 1994-07-18 1,5- Benzodiazepine derivatives and their use in medicine
FI943421A FI111632B (fi) 1992-01-21 1994-07-19 Menetelmä CCK-B-antagonistisesti vaikuttavien 1,5-bentsodiatsepiinijohdannaisten valmistamiseksi
NO942720A NO305952B1 (no) 1992-01-21 1994-07-20 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
HU95P/P00242P HU211295A9 (en) 1992-01-21 1995-06-16 1,5-benzodiazepine derivatives
US08/674,259 US5637697A (en) 1992-01-21 1996-07-01 1,5-benzodiazepine derivatives and their use in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929201180A GB9201180D0 (en) 1992-01-21 1992-01-21 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9201180D0 true GB9201180D0 (en) 1992-03-11

Family

ID=10708914

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929201180A Pending GB9201180D0 (en) 1992-01-21 1992-01-21 Chemical compounds

Country Status (29)

Country Link
US (2) US5580895A (OSRAM)
JP (1) JP3253723B2 (OSRAM)
KR (1) KR100263625B1 (OSRAM)
CN (1) CN1049217C (OSRAM)
AP (1) AP369A (OSRAM)
AU (2) AU3450193A (OSRAM)
BG (1) BG61876B1 (OSRAM)
CA (1) CA2087672C (OSRAM)
CZ (1) CZ283950B6 (OSRAM)
FI (1) FI111632B (OSRAM)
GB (1) GB9201180D0 (OSRAM)
GE (1) GEP20001968B (OSRAM)
HU (2) HU221297B1 (OSRAM)
IL (1) IL104447A (OSRAM)
IS (1) IS3970A (OSRAM)
MX (1) MX9300261A (OSRAM)
MY (1) MY131307A (OSRAM)
NO (1) NO305952B1 (OSRAM)
NZ (1) NZ245715A (OSRAM)
OA (1) OA09964A (OSRAM)
PH (1) PH30894A (OSRAM)
PL (1) PL175340B1 (OSRAM)
RO (1) RO114128B1 (OSRAM)
RU (1) RU2124009C1 (OSRAM)
SK (1) SK280173B6 (OSRAM)
TW (1) TW226013B (OSRAM)
UA (1) UA29416C2 (OSRAM)
WO (1) WO1993014074A1 (OSRAM)
ZA (1) ZA93375B (OSRAM)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
JPH08508743A (ja) * 1993-04-15 1996-09-17 グラクソ、ウェルカム、インコーポレーテッド Ｃｃｋおよび／またはガストリン拮抗作用を有する１，５−ベンゾジアゼピン誘導体
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
GB9308431D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9308421D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB9315018D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB9314977D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB2280182A (en) * 1993-07-20 1995-01-25 Glaxo Spa Benzodiazepine derivatives
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
KR970702274A (ko) * 1994-04-14 1997-05-13 앨런 헤스케쓰 콜레시스토키닌 또는 가스트린을 조절하는 5-헤테로시클릭-1, 5-벤조디아제핀(CCK or Gastrin Modulating 5-Heterocyclic-1,5-Benzodiazepines)
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
US5780464A (en) * 1994-10-14 1998-07-14 Glaxo Wellcome Inc. Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
GB9420748D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
CA2239293A1 (en) 1995-12-11 1997-06-19 New England Medical Center Hosptials, Inc. Assay for and uses of peptide hormone receptor ligands
CA2274669C (en) * 1996-12-10 2006-11-14 Zeria Pharmaceutical Co., Ltd. 1,5-benzodiazepine derivatives
RU2321583C2 (ru) * 2001-01-22 2008-04-10 Мемори Фармасьютиклз Корпорейшн Применение производных анилина в качестве ингибиторов фосфодиэстеразы 4
ATE552236T1 (de) * 2003-01-14 2012-04-15 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz
GB0307918D0 (en) * 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
NZ547880A (en) * 2003-11-18 2010-02-26 Boehringer Ingelheim Int Solid pharmaceutical preparation form
KR101276136B1 (ko) 2004-06-17 2013-06-18 싸이토키네틱스, 인코포레이티드 화합물, 조성물 및 방법
US7538223B2 (en) 2005-08-04 2009-05-26 Cytokinetics, Inc. Compounds, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
EP1959960B1 (en) 2005-12-15 2013-04-10 Cytokinetics, Inc. Certain chemical entities, compositions and methods
US7718657B2 (en) 2005-12-16 2010-05-18 Cytokinetics, Inc. Certain indanyl urea modulators of the cardiac sarcomere
US7989455B2 (en) 2005-12-19 2011-08-02 Cytokinetics, Inc. Compounds, compositions and methods
CU20090172A7 (es) 2009-10-09 2011-10-05 Ct De Investigación Y Desarrollo De Medicamentos Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
ES2613808T3 (es) 2011-07-29 2017-05-26 Oncotherapy Science, Inc. Péptido derivado de ERAP1 y uso del mismo
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
JP7112324B2 (ja) 2015-07-22 2022-08-03 エナンタ ファーマシューティカルズ インコーポレイテッド Ｒｓｖ阻害剤としてのベンゾジアゼピン誘導体
US20170226129A1 (en) 2016-01-15 2017-08-10 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
JP7076459B2 (ja) 2017-02-16 2022-05-27 エナンタ ファーマシューティカルズ インコーポレイテッド ベンゾジアゼピン誘導体の製造プロセス
US10752598B2 (en) * 2017-06-07 2020-08-25 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as RSV inhibitors
WO2019006295A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
WO2019006291A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
US10881666B2 (en) 2017-09-29 2021-01-05 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as RSV inhibitors
WO2019094920A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as rsv inhibitors
US10975094B2 (en) 2018-04-11 2021-04-13 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
EP3889264A4 (en) 2018-11-30 2022-10-12 Tokushima University Therapeutic agent for breast caner comprising big3-phb2 interaction-inhibiting peptide derived from phb2
EP3941525A4 (en) 2019-03-18 2022-12-07 Enanta Pharmaceuticals, Inc. BENZODIAZEPIN DERIVATIVES AS RSV INHIBITORS
WO2020210246A1 (en) 2019-04-09 2020-10-15 Enanta Pharmaceuticals, Inc, Heterocyclic compounds as rsv inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en) 2020-07-07 2022-12-27 Enanta Pharmaceuticals, Inc. Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
AR129003A1 (es) 2022-04-07 2024-07-03 Enanta Pharm Inc Compuestos heterocíclicos antivirales
US12162857B2 (en) 2022-04-27 2024-12-10 Enanta Pharmaceuticals, Inc. Antiviral compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984398A (en) * 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
US4207228A (en) * 1977-09-21 1980-06-10 The B. F. Goodrich Company UV-Light-stabilized compositions containing substituted 1,5-diazacycloalkanes, novel compounds and synthesis thereof
JPS60158190A (ja) * 1984-01-30 1985-08-19 Eisai Co Ltd ヒダントイン誘導体およびその製法ならびにそれを含有する医薬
US4647561A (en) * 1985-08-05 1987-03-03 E. R. Squibb & Sons, Inc. 1,5-benzodiazepine compounds
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
BG61876B1 (bg) 1998-08-31
CN1049217C (zh) 2000-02-09
GEP20001968B (en) 2000-03-05
HU211295A9 (en) 1995-11-28
AP369A (en) 1994-11-06
HUT67375A (en) 1995-03-28
CN1074678A (zh) 1993-07-28
NO942720D0 (no) 1994-07-20
UA29416C2 (uk) 2000-11-15
NZ245715A (en) 1995-07-26
US5580895A (en) 1996-12-03
RO114128B1 (ro) 1999-01-29
IS3970A (is) 1993-07-22
AU3193593A (en) 1993-07-22
KR100263625B1 (ko) 2000-11-01
PH30894A (en) 1997-12-23
JPH07118244A (ja) 1995-05-09
SK280173B6 (sk) 1999-09-10
HU9402150D0 (en) 1994-09-28
RU2124009C1 (ru) 1998-12-27
FI943421A0 (fi) 1994-07-19
CA2087672C (en) 2003-08-05
SK86494A3 (en) 1995-03-08
FI943421L (fi) 1994-07-19
AU3450193A (en) 1993-08-03
CZ173694A3 (en) 1995-09-13
JP3253723B2 (ja) 2002-02-04
US5637697A (en) 1997-06-10
FI111632B (fi) 2003-08-29
ZA93375B (en) 1994-07-18
PL175340B1 (pl) 1998-12-31
CA2087672A1 (en) 1993-07-22
RU94037768A (ru) 1996-08-10
NO942720L (no) 1994-07-20
OA09964A (en) 1995-12-11
AU661749B2 (en) 1995-08-03
IL104447A (en) 1998-02-22
AP9300478A0 (en) 1993-01-31
BG98881A (bg) 1995-03-31
NO305952B1 (no) 1999-08-23
MY131307A (en) 2007-08-30
TW226013B (OSRAM) 1994-07-01
WO1993014074A1 (en) 1993-07-22
CZ283950B6 (cs) 1998-07-15
MX9300261A (es) 1994-03-31
IL104447A0 (en) 1993-05-13
HU221297B1 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
GB9201179D0 (en) Chemical compounds
GB9201180D0 (en) Chemical compounds
GB9202915D0 (en) Chemical compounds
GB9201038D0 (en) Chemical compounds
GB9208740D0 (en) Chemical compounds
AP9300585A0 (en) Chemical compounds
GB9209076D0 (en) Chemical compounds
GB9207964D0 (en) Chemical compounds
GB9206989D0 (en) Chemical compounds
GB9205136D0 (en) Chemical compounds
GB9205140D0 (en) Chemical compounds
GB9202840D0 (en) Chemical compounds
GB9201171D0 (en) Chemical compounds
GB9201176D0 (en) Chemical compounds
GB9201182D0 (en) Chemical compounds
GB9201183D0 (en) Chemical compounds
GB9201184D0 (en) Chemical compounds
GB9201196D0 (en) Chemical compounds
GB9201358D0 (en) Chemical compounds
GB9201802D0 (en) Chemical compounds
GB9201821D0 (en) Chemical compounds
GB9202200D0 (en) Chemical compounds
GB9202839D0 (en) Chemical compounds
GB9201173D0 (en) Chemical compounds
GB9201172D0 (en) Chemical compounds